# No-write Boundary Results

Phase 10C remains inside the read-only and no-write boundary.

## Confirmed No-write Scope

- No FHIR write was added.
- No FHIR create, update, delete, patch, upload, purge, or expunge flow was added.
- No lesion create, edit, update, delete, approve, signoff, or persist behavior was added.
- No formal ingestion path was added.
- No guidance for production ingestion was added.
- No approval or signoff bypass was added.
- No guidance for clinical data mutation was added.
- No patient, observation, Rekam, practitioner, DocumentReference, or Binary mutation flow was changed.

## Mock Preview Boundary

The mock ingestion preview remains:

- Dev-only.
- Mock-only.
- Preview-only.
- No FHIR write.
- Not persisted.
- Pending manual review.
- Not signed off.

The preview is evidence of candidate display generation only. It is not clinical persistence and not production ingestion.
